“[Complementary Strategy of RSVpreF Vaccination Nirsevimab Versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]”. Farmeconomia. Health Economics and Therapeutic Pathways 26, no. 1 (July 29, 2025). Accessed February 4, 2026. https://journals.seedstm.com/index.php/FE/article/view/1583.